Iovance Biotherapeutics (IOVA)
4.34
-0.04 (0.91%)
Upcoming Events
Latest Headlines
Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 01 Filed by: Vogt Frederick G
June 3, 2026 5:02 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 01 Filed by: Puri Raj K.
June 3, 2026 5:01 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 01 Filed by: GRAF FINCKENSTEIN FRIEDRICH
June 3, 2026 5:01 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 01 Filed by: BILINSKY IGOR
June 3, 2026 5:00 PM - SEC Filing
Iovance receives Australia approval for melanoma therapy Amtagvi
June 3, 2026 4:09 PM - StreetInsider
Iovance’s Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia
June 3, 2026 4:05 PM - StreetInsider
How Advanced Drug Delivery Could Improve Existing Cancer Treatments
June 1, 2026 8:30 AM - StreetInsider
Iovance receives FDA clearance for IL-12 tethered TIL therapy trial
June 1, 2026 7:31 AM - StreetInsider
Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001
June 1, 2026 7:30 AM - StreetInsider
Iovanace Biotherapeutics (IOVA) Reiterated at Market Outperform by Citizens
June 1, 2026 4:40 AM - StreetInsider
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
May 22, 2026 5:15 PM - StreetInsider
Iovance Biotherapeutics to Present at Upcoming Conference
May 21, 2026 8:05 AM - StreetInsider
Form 4 IOVANCE BIOTHERAPEUTICS, For: May 11 Filed by: Kirby Daniel Gordon
May 13, 2026 5:00 PM - SEC Filing
Form SCHEDULE 13G IOVANCE BIOTHERAPEUTICS, Filed by: STATE STREET CORP
May 12, 2026 11:17 AM - SEC Filing
Intellia short interest rises most among biotech stocks in latest period - Baird
May 12, 2026 9:58 AM - StreetInsider
Form 8-K IOVANCE BIOTHERAPEUTICS, For: May 07
May 7, 2026 9:18 AM - SEC Filing
Form 10-Q IOVANCE BIOTHERAPEUTICS, For: Mar 31
May 7, 2026 9:17 AM - SEC Filing
Iovance Biotherapeutics (IOVA) Misses Q1 EPS by 5c ; Offers Guidance
May 7, 2026 7:17 AM - StreetInsider
Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates
May 7, 2026 7:05 AM - Globe NewsWire
Form ARS IOVANCE BIOTHERAPEUTICS, For: Dec 31
May 1, 2026 5:01 PM - SEC Filing
Form DEFA14A IOVANCE BIOTHERAPEUTICS,
April 28, 2026 5:05 PM - SEC Filing
Form DEF 14A IOVANCE BIOTHERAPEUTICS, For: Jun 10
April 28, 2026 5:01 PM - SEC Filing
Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026
April 27, 2026 8:01 AM - Globe NewsWire
H.C. Wainwright Reiterates Buy Rating on Iovanace Biotherapeutics (IOVA)
April 22, 2026 6:42 AM - StreetInsider
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
April 17, 2026 5:15 PM - StreetInsider
Form PRE 14A IOVANCE BIOTHERAPEUTICS, For: Jun 10
April 17, 2026 5:01 PM - SEC Filing
Jefferies on Iovanace Biotherapeutics (IOVA): 'we think the pot'l risk of competition was accounted for in Street models'
April 10, 2026 1:20 PM - StreetInsider
Form SCHEDULE 13G/A IOVANCE BIOTHERAPEUTICS, Filed by: VANGUARD GROUP INC
March 27, 2026 9:52 AM - SEC Filing
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
March 20, 2026 5:15 PM - StreetInsider
Form 8-K IOVANCE BIOTHERAPEUTICS, For: Mar 17
March 20, 2026 5:01 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Mar 09 Filed by: Roche Corleen M.
March 11, 2026 5:25 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Mar 09 Filed by: Vogt Frederick G
March 11, 2026 5:08 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Mar 09 Filed by: Puri Raj K.
March 11, 2026 5:05 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Mar 09 Filed by: GRAF FINCKENSTEIN FRIEDRICH
March 11, 2026 5:03 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Mar 09 Filed by: Kirby Daniel Gordon
March 11, 2026 5:01 PM - SEC Filing
Form 4 IOVANCE BIOTHERAPEUTICS, For: Mar 09 Filed by: BILINSKY IGOR
March 11, 2026 5:00 PM - SEC Filing
Full Article List
